Showing results (1-10 of 642) with videos related to
Sort By:
Pageof 65
Arthritis and Rheumatism|April 16, 2002
Laboratory testing in rheumatoid arthritis patients taking disease-modifying antirheumatic drugs: clinical evaluation and cost analysisDaniel Aletaha, Josef S SmolenRheumatic Diseases Clinics of North America|December 8, 2009
The Simplified Disease Activity Index and Clinical Disease Activity Index to monitor patients in standard clinical careDaniel Aletaha, Josef S SmolenArthritis and Rheumatism|September 29, 2011
Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen jointsDaniel Aletaha, Josef S SmolenNature Reviews. Rheumatology|February 18, 2015
Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challengesJosef S Smolen, Daniel AletahaAnnals of the Rheumatic Diseases|November 9, 2012
Forget personalised medicine and focus on abating disease activityJosef S Smolen, Daniel AletahaClinical and Experimental Rheumatology|June 26, 2010
The assessment of disease activity in rheumatoid arthritisJosef S Smolen, Daniel AletahaCurrent Opinion in Rheumatology|April 5, 2008
Activity assessments in rheumatoid arthritisJosef S Smolen, Daniel AletahaThe Journal of Rheumatology|August 16, 2002
Effectiveness profiles and dose dependent retention of traditional disease modifying antirheumatic drugs for rheumatoid arthritis. An observational studyDaniel Aletaha, Josef S SmolenArthritis and Rheumatism|January 5, 2011
Interleukin-6 receptor inhibition with tocilizumab and attainment of disease remission in rheumatoid arthritis: the role of acute-phase reactantsJosef S Smolen, Daniel AletahaJAMA|October 5, 2018
Diagnosis and Management of Rheumatoid Arthritis: A ReviewDaniel Aletaha, Josef S SmolenPageof 65